Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Briley

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
International Journal of Psychiatry in Clinical Practice|June 18, 2014
Five years experience of prescribing milnacipran: An interview with Didier Papeta (Head of Psychiatry, General Military Hospital, Brest, France)Mike Briley
Human Psychopharmacology|September 21, 2004
Clinical experience with dual action antidepressants in different chronic pain syndromesMike Briley
Current Opinion in Investigational Drugs (London, England : 2000)|January 5, 2010
Drugs to treat fibromyalgia - the transatlantic differenceMike Briley
Current Opinion in Investigational Drugs (London, England : 2000)|March 11, 2003
New hope in the treatment of painful symptoms in depressionMike Briley
Neuropsychiatric Disease and Treatment|October 20, 2010
Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitorsMike Briley, Chantal Moret
Neuropsychiatric Disease and Treatment|May 5, 2009
Antidepressants in the treatment of fibromyalgiaChantal Moret, Mike Briley
Idrugs : the Investigational Drugs Journal|July 16, 2003
Fibromyalgia syndrome: an overview of potential drug targetsMike Briley, Chantal Moret
Human Psychopharmacology|September 21, 2004
Understanding pain in depressionStephen Stahl, Mike Briley
Neuropsychiatric Disease and Treatment|March 21, 2009
Japanese experience with milnacipran, the first serotonin and norepinephrine reuptake inhibitor in JapanTeruhiko Higuchi, Mike Briley
CNS Spectrums|December 17, 2008
Treatment of comorbid pain with serotonin norepinephrine reuptake inhibitorsMike Briley, Chantal Moret
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
International Journal of Psychiatry in Clinical Practice|June 18, 2014
Five years experience of prescribing milnacipran: An interview with Didier Papeta (Head of Psychiatry, General Military Hospital, Brest, France)Mike Briley
Human Psychopharmacology|September 21, 2004
Clinical experience with dual action antidepressants in different chronic pain syndromesMike Briley
Current Opinion in Investigational Drugs (London, England : 2000)|January 5, 2010
Drugs to treat fibromyalgia - the transatlantic differenceMike Briley
Current Opinion in Investigational Drugs (London, England : 2000)|March 11, 2003
New hope in the treatment of painful symptoms in depressionMike Briley
Neuropsychiatric Disease and Treatment|October 20, 2010
Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitorsMike Briley, Chantal Moret
Neuropsychiatric Disease and Treatment|May 5, 2009
Antidepressants in the treatment of fibromyalgiaChantal Moret, Mike Briley
Idrugs : the Investigational Drugs Journal|July 16, 2003
Fibromyalgia syndrome: an overview of potential drug targetsMike Briley, Chantal Moret
Human Psychopharmacology|September 21, 2004
Understanding pain in depressionStephen Stahl, Mike Briley
Neuropsychiatric Disease and Treatment|March 21, 2009
Japanese experience with milnacipran, the first serotonin and norepinephrine reuptake inhibitor in JapanTeruhiko Higuchi, Mike Briley
CNS Spectrums|December 17, 2008
Treatment of comorbid pain with serotonin norepinephrine reuptake inhibitorsMike Briley, Chantal Moret
Pageof 3